E2F1 and neoplasm: In this respect, it would be interesting to use single-cell sequencing approaches to track the evolutionary trajectory of a BC tumor and unveil whether E2F1-triggered c-NHEJ dysregulation might consist one of the mechanisms orchestrating the evolutionary adaptation towards aggressiveness and resistance to therapy.